These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 778835)

  • 1. Cyclophosphamide (CP) substituting azathioprine after renal transplantation.
    Andreu J; Caralps A; Brulles A; Lloveras J; Masramon J; Gil-Vernet JM
    Proc Eur Dial Transplant Assoc; 1976; 12():434-40. PubMed ID: 778835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cyclophosphamide therapy in kidney transplants].
    Stummvoll HK; Egert H; Böhmig HJ; Pinggera WF
    Wien Z Inn Med; 1973; 54(4):145-9. PubMed ID: 4587180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cyclophosphamide in renal transplantation].
    Guerra C; Andreu J; Tinaut J; Masaramón J; Lloveras J
    Actas Urol Esp; 1977; 1(4):195-200. PubMed ID: 354338
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclophosphamide and whole organ transplantation in human beings.
    Starzl TE; Putnam CW; Halgrimson CG; Schroter GT; Martineau G; Launois B; Corman JL; Penn I; Booth AS; Groth CG; Porter KA
    Surg Gynecol Obstet; 1971 Dec; 133(6):981-91. PubMed ID: 4940540
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective, randomized comparison of cyclophosphamide and azathioprine for early rejection prophylaxis after cardiac transplantation. Decreased sensitization to OKT3.
    Taylor DO; Bristow MR; O'Connell JB; Ensley RD; Olsen SL; Hammond EH; Wagoner LE; Renlund DG
    Transplantation; 1994 Sep; 58(6):645-9. PubMed ID: 7940682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal transplantation under cyclophosphamide.
    Starzl TE; Putnam CW; Halgrimson CG; Groth CG; Booth AS; Penn I
    Transplant Proc; 1972 Dec; 4(4):461-4. PubMed ID: 4566786
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression with cyclophosphamide in the dog.
    Putnam CW; Halgrimson CG; Groth CG; Kashiwagi N; Porter KA; Starzl TE
    Clin Exp Immunol; 1975 Nov; 22(2):323-9. PubMed ID: 765024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic veno-occlusive disease in a renal transplant patient receiving azathioprine.
    Marubbio AT; Danielson B
    Gastroenterology; 1975 Sep; 69(3):739-43. PubMed ID: 1098955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic dysfunction in recipients of renal allografts.
    Berne TV; Chatterjee SN; Craig JR; Payne JE
    Surg Gynecol Obstet; 1975 Aug; 141(2):171-5. PubMed ID: 168654
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunosuppressive effect of bredinin in the management of patients with renal transplantation.
    Kusaba R; Otubo O; Sugimoto H; Takahashi I; Yamada Y; Yamauchi J; Akiyama N; Inou T
    Proc Eur Dial Transplant Assoc; 1981; 18():420-5. PubMed ID: 7036163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drugs used in clinical renal transplantation.
    Chatterjee SN
    Urology; 1977 Jun; 9(6 Suppl):52-60. PubMed ID: 70101
    [No Abstract]   [Full Text] [Related]  

  • 12. Liver disease in kidney transplant patients receiving azathioprine.
    Ireland P; Rashid A; von Lichtenberg F; Cavallo T; Merrill JP
    Arch Intern Med; 1973 Jul; 132(1):29-37. PubMed ID: 4577390
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical renal transplantation.
    Kountz SL
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic immunosuppression, Australia antigenemia, and hepatitis.
    Starzl TE; Putnam CW
    Transplant Proc; 1972 Dec; 4(4):685-6. PubMed ID: 4566819
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclophosphamide for clinical renal and hepatic transplantation.
    Starzl TE; Groth CG; Putnam CW; Corman J; Halgrimson CG; Penn I; Husberg B; Gustafsson A; Cascardo S; Geis P; Iwatsuki S
    Transplant Proc; 1973 Mar; 5(1):511-6. PubMed ID: 4572111
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunosuppression in live-related donor renal transplantation.
    Iman A; Rao M; Juneja R; Jacob CK
    Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of the immunosuppressive action of azathioprine and cyclophosphamide in experimental homologous liver transplant].
    da Cunha JE; Machado MC; Bacchella T; Margarido NF; Lima-Gonçalves E
    Rev Hosp Clin Fac Med Sao Paulo; 1977 Jun; 32(3):166-9. PubMed ID: 341264
    [No Abstract]   [Full Text] [Related]  

  • 18. Irreversible liver damage after azathioprine.
    Zarday Z; Veith FJ; Gliedman ML; Soberman R
    JAMA; 1972 Nov; 222(6):690-1. PubMed ID: 4562099
    [No Abstract]   [Full Text] [Related]  

  • 19. Spectrum of liver disease in renal transplant recipients.
    Ware AJ; Luby JP; Eigenbrodt EH; Long DL; Hull AR
    Gastroenterology; 1975 Apr; 68(4 Pt 1):755-64. PubMed ID: 164401
    [No Abstract]   [Full Text] [Related]  

  • 20. Optimization of immunosuppression by switching from azathioprine to enteric-coated mycophenolate sodium in stable kidney transplant patients.
    Gutiérrez Sánchez MJ; Morales Cerdán JM; Belmonte AA
    Transplant Proc; 2009; 41(6):2320-2. PubMed ID: 19715907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.